These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 12490682

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: the effective delivered dose.
    Depner T.
    Semin Dial; 2008; 21(5):405-7. PubMed ID: 18945326
    [No Abstract] [Full Text] [Related]

  • 23. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT.
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [Abstract] [Full Text] [Related]

  • 24. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R, Polkinghorne KR, Kerr PG.
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint.
    Locatelli F.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1061-5. PubMed ID: 12748335
    [No Abstract] [Full Text] [Related]

  • 29. Advantages of new hemodialysis membranes and equipment.
    Vanholder R, Glorieux G, Van Biesen W.
    Nephron Clin Pract; 2010 Jun; 114(3):c165-72. PubMed ID: 19955821
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: "difficult to remove" uremic toxins.
    Vanholder R, Eloot S, Van Biesen W.
    Semin Dial; 2008 Jun; 21(5):407-9. PubMed ID: 18945327
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L, Haragsim L.
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [Abstract] [Full Text] [Related]

  • 35. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [Abstract] [Full Text] [Related]

  • 36. Nerve conduction studies and prediction of mortality in hemodialysis patients.
    Stosovic M, Nikolic A, Stanojevic M, Simic-Ogrizovic S, Radovic M, Jovanovic D, Popovic Z, Trikic R, Djukanovic L.
    Ren Fail; 2008 Mar; 30(7):695-9. PubMed ID: 18704818
    [Abstract] [Full Text] [Related]

  • 37. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
    Puskar D, Pasini J, Savić I, Bedalov G, Sonicki Z.
    Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
    [Abstract] [Full Text] [Related]

  • 38. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A, Sperschneider H, Winnefeld K, Günther K, Stein G.
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.